Peter E Penson

Dr. Peter E. Penson is a Professor of Pharmacy Practice at Liverpool John Moores University, where he also serves as Head of Subject (Pharmacy) and Lead Pharmacist in the School of Pharmacy & Biomolecular Sciences. He holds a PhD in Cardiovascular Pharmacology from Cardiff University and has been a key academic and research figure at LJMU since 2009. He is Editor-in-Chief of Expert Review of Clinical Pharmacology and actively contributes to international lipid and cardiovascular expert panels.

• PhD in Cardiovascular Pharmacology, Cardiff University (2005–2009)

Dr. Penson's research centers on cardiovascular pharmacology, lipid therapeutics, and clinical pharmacology. His expertise includes meta-analyses, statin therapy, combination lipid-lowering treatments, anticoagulation, and the management of dyslipidemia and hypertension. He frequently collaborates with the International Lipid Expert Panel (ILEP) and contributes to major position papers and clinical guidelines. His work leverages real-world data, registry studies, and systematic reviews to inform clinical practice.

The 15 most recent articles highlight a strong focus on lipid-lowering therapies, particularly upfront combination strategies with statins and ezetimibe, cardiovascular prevention, meta-analyses, and clinical outcomes in atrial fibrillation and hypertension. His publications appear in high-impact journals such as Mayo Clinic Proceedings, European Heart Journal, and Cardiovascular Research, reflecting his influence in cardiovascular therapeutics and pharmacology.

Dr. Penson has no listed scientific awards in the provided text, but his editorial leadership and extensive publication record underscore his academic prominence.

He advises or mentors no students listed in the data, but his collaborative research involves numerous international scholars. He has received funding from Liverpool John Moores University for research on Daphnia as a model for cardiovascular therapeutics, indicating active grant involvement.

He leads or is part of research teams focused on cardiovascular disease prevention, lipid management, and pharmacotherapy optimization, often in collaboration with multidisciplinary experts and institutions like the University of Liverpool.